NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution
Human cystatin C (hCC), a member of the superfamily of papain‐like cysteine protease inhibitors, is the most widespread cystatin in human body fluids. This small protein, in addition to its physiological function, is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemor...
Gespeichert in:
Veröffentlicht in: | The FEBS journal 2020-01, Vol.287 (2), p.361-376 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 376 |
---|---|
container_issue | 2 |
container_start_page | 361 |
container_title | The FEBS journal |
container_volume | 287 |
creator | Maszota‐Zieleniak, Martyna Jurczak, Przemyslaw Orlikowska, Marta Zhukov, Igor Borek, Dominika Otwinowski, Zbyszek Skowron, Piotr Pietralik, Zuzanna Kozak, Maciej Szymańska, Aneta Rodziewicz‐Motowidło, Sylwia |
description | Human cystatin C (hCC), a member of the superfamily of papain‐like cysteine protease inhibitors, is the most widespread cystatin in human body fluids. This small protein, in addition to its physiological function, is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, stroke, and dementia. Physiologically active hCC is a monomer. However, all structural studies based on crystallization led to the dimeric structure formed as a result of a three‐dimensional exchange of the protein domains (3D domain swapping). The monomeric structure was obtained only for hCC variant V57N and for the protein stabilized by an additional disulfide bridge. With this study, we extend the number of models of monomeric hCC by an additional hCC variant with a single amino acid substitution in the flexible loop L1. The V57G variant was chosen for the X‐ray and NMR structural analysis due to its exceptional conformational stability in solution. In this work, we show for the first time the structural and dynamics studies of human cystatin C variant in solution. We were also able to compare these data with the crystal structure of the hCC V57G and with other cystatins. The overall cystatin fold is retained in the solute form. Additionally, structural information concerning the N terminus was obtained during our studies and presented for the first time.
Database
Crystallographic structure: structural data are available in PDB databases under the accession number 6ROA. NMR structure: structural data are available in PDB and BMRB databases under the accession numbers 6RPV and 34399, respectively.
Human cystatin C (hCC), a cysteine protease inhibitor, is the most widespread cystatin in human body fluids. In addition to physiological functions, it is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, and dementia. With this study, we extend the number of X‐ray and NMR structural models of monomeric hCC by an additional variant exhibiting exceptional conformational stability. |
doi_str_mv | 10.1111/febs.15010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_1601851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2341543322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4200-b78911860bf8809a27f11c1ae026c03d3b4a154991ba6296cb604eff9b8f067c3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqWw4QGQBRuENMWXjJMsYdQCUgGJi8TOsp3jxpVjD75Q5iF4ZxxSumCBNz6Sv_PZx3_TPCb4lNT10oBKp2SLCb7THJOupZuWb_u7t3X77ah5kNIVxmzbDsP95ogRxjDuuuPm14f3n5D0I9LxkLJ0LlxGuZ-sRinHonOJ0tWyjBYSCgblCRD8zBFmcId6IJUDNAcfZoi16YeMVvq8kFOZpUd6sWbr0Q5d2zyhZP1l7ZCz9QFJbUeUikrZ5pJt8A-be0a6BI9u9pPm6_nZl93bzcXHN-92ry42uqUYb1TXD4T0HCvT93iQtDOEaCIBU64xG5lqJVlGJUpyOnCtOG7BmEH1BvNOs5Pm6eoN9WqRtM2gJx28B50F4Zj0W1Kh5yu0j-F7gZTFbJMG56SHUJKglHfdsHx1RZ_9g16FEn0dQVDW1qcwRmmlXqyUjiGlCEbso51lPAiCxZKkWJIUf5Ks8JMbZVEzjLfo3-gqQFbg2jo4_Eclzs9ef16lvwEVu6nq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2341543322</pqid></control><display><type>article</type><title>NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Free Content</source><source>Free Full-Text Journals in Chemistry</source><creator>Maszota‐Zieleniak, Martyna ; Jurczak, Przemyslaw ; Orlikowska, Marta ; Zhukov, Igor ; Borek, Dominika ; Otwinowski, Zbyszek ; Skowron, Piotr ; Pietralik, Zuzanna ; Kozak, Maciej ; Szymańska, Aneta ; Rodziewicz‐Motowidło, Sylwia</creator><creatorcontrib>Maszota‐Zieleniak, Martyna ; Jurczak, Przemyslaw ; Orlikowska, Marta ; Zhukov, Igor ; Borek, Dominika ; Otwinowski, Zbyszek ; Skowron, Piotr ; Pietralik, Zuzanna ; Kozak, Maciej ; Szymańska, Aneta ; Rodziewicz‐Motowidło, Sylwia ; Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><description>Human cystatin C (hCC), a member of the superfamily of papain‐like cysteine protease inhibitors, is the most widespread cystatin in human body fluids. This small protein, in addition to its physiological function, is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, stroke, and dementia. Physiologically active hCC is a monomer. However, all structural studies based on crystallization led to the dimeric structure formed as a result of a three‐dimensional exchange of the protein domains (3D domain swapping). The monomeric structure was obtained only for hCC variant V57N and for the protein stabilized by an additional disulfide bridge. With this study, we extend the number of models of monomeric hCC by an additional hCC variant with a single amino acid substitution in the flexible loop L1. The V57G variant was chosen for the X‐ray and NMR structural analysis due to its exceptional conformational stability in solution. In this work, we show for the first time the structural and dynamics studies of human cystatin C variant in solution. We were also able to compare these data with the crystal structure of the hCC V57G and with other cystatins. The overall cystatin fold is retained in the solute form. Additionally, structural information concerning the N terminus was obtained during our studies and presented for the first time.
Database
Crystallographic structure: structural data are available in PDB databases under the accession number 6ROA. NMR structure: structural data are available in PDB and BMRB databases under the accession numbers 6RPV and 34399, respectively.
Human cystatin C (hCC), a cysteine protease inhibitor, is the most widespread cystatin in human body fluids. In addition to physiological functions, it is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, and dementia. With this study, we extend the number of X‐ray and NMR structural models of monomeric hCC by an additional variant exhibiting exceptional conformational stability.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.15010</identifier><identifier>PMID: 31330077</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Amino acid substitution ; Amino acids ; Amyloid ; Body fluids ; Cerebral amyloid angiopathy ; Computational fluid dynamics ; Crystal structure ; Crystallization ; Crystallography ; Cystatin C ; Cysteine proteinase ; Dementia disorders ; Disulfide bonds ; Dynamic structural analysis ; hCC V57G variant ; Hemorrhage ; human cystatin C ; NMR ; Nuclear magnetic resonance ; Papain ; Protease inhibitors ; protein structure ; Proteinase inhibitors ; Proteins ; Stability analysis ; Structural analysis ; Substitutes ; X‐ray</subject><ispartof>The FEBS journal, 2020-01, Vol.287 (2), p.361-376</ispartof><rights>2019 Federation of European Biochemical Societies</rights><rights>2019 Federation of European Biochemical Societies.</rights><rights>Copyright © 2020 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4200-b78911860bf8809a27f11c1ae026c03d3b4a154991ba6296cb604eff9b8f067c3</citedby><cites>FETCH-LOGICAL-c4200-b78911860bf8809a27f11c1ae026c03d3b4a154991ba6296cb604eff9b8f067c3</cites><orcidid>0000-0001-7962-3953 ; 0000-0002-4321-6253 ; 0000-0002-8664-2041 ; 0000000243216253 ; 0000000286642041 ; 0000000179623953</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ffebs.15010$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ffebs.15010$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,777,781,882,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31330077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/1601851$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Maszota‐Zieleniak, Martyna</creatorcontrib><creatorcontrib>Jurczak, Przemyslaw</creatorcontrib><creatorcontrib>Orlikowska, Marta</creatorcontrib><creatorcontrib>Zhukov, Igor</creatorcontrib><creatorcontrib>Borek, Dominika</creatorcontrib><creatorcontrib>Otwinowski, Zbyszek</creatorcontrib><creatorcontrib>Skowron, Piotr</creatorcontrib><creatorcontrib>Pietralik, Zuzanna</creatorcontrib><creatorcontrib>Kozak, Maciej</creatorcontrib><creatorcontrib>Szymańska, Aneta</creatorcontrib><creatorcontrib>Rodziewicz‐Motowidło, Sylwia</creatorcontrib><creatorcontrib>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><title>NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>Human cystatin C (hCC), a member of the superfamily of papain‐like cysteine protease inhibitors, is the most widespread cystatin in human body fluids. This small protein, in addition to its physiological function, is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, stroke, and dementia. Physiologically active hCC is a monomer. However, all structural studies based on crystallization led to the dimeric structure formed as a result of a three‐dimensional exchange of the protein domains (3D domain swapping). The monomeric structure was obtained only for hCC variant V57N and for the protein stabilized by an additional disulfide bridge. With this study, we extend the number of models of monomeric hCC by an additional hCC variant with a single amino acid substitution in the flexible loop L1. The V57G variant was chosen for the X‐ray and NMR structural analysis due to its exceptional conformational stability in solution. In this work, we show for the first time the structural and dynamics studies of human cystatin C variant in solution. We were also able to compare these data with the crystal structure of the hCC V57G and with other cystatins. The overall cystatin fold is retained in the solute form. Additionally, structural information concerning the N terminus was obtained during our studies and presented for the first time.
Database
Crystallographic structure: structural data are available in PDB databases under the accession number 6ROA. NMR structure: structural data are available in PDB and BMRB databases under the accession numbers 6RPV and 34399, respectively.
Human cystatin C (hCC), a cysteine protease inhibitor, is the most widespread cystatin in human body fluids. In addition to physiological functions, it is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, and dementia. With this study, we extend the number of X‐ray and NMR structural models of monomeric hCC by an additional variant exhibiting exceptional conformational stability.</description><subject>Amino acid substitution</subject><subject>Amino acids</subject><subject>Amyloid</subject><subject>Body fluids</subject><subject>Cerebral amyloid angiopathy</subject><subject>Computational fluid dynamics</subject><subject>Crystal structure</subject><subject>Crystallization</subject><subject>Crystallography</subject><subject>Cystatin C</subject><subject>Cysteine proteinase</subject><subject>Dementia disorders</subject><subject>Disulfide bonds</subject><subject>Dynamic structural analysis</subject><subject>hCC V57G variant</subject><subject>Hemorrhage</subject><subject>human cystatin C</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Papain</subject><subject>Protease inhibitors</subject><subject>protein structure</subject><subject>Proteinase inhibitors</subject><subject>Proteins</subject><subject>Stability analysis</subject><subject>Structural analysis</subject><subject>Substitutes</subject><subject>X‐ray</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUhiMEoqWw4QGQBRuENMWXjJMsYdQCUgGJi8TOsp3jxpVjD75Q5iF4ZxxSumCBNz6Sv_PZx3_TPCb4lNT10oBKp2SLCb7THJOupZuWb_u7t3X77ah5kNIVxmzbDsP95ogRxjDuuuPm14f3n5D0I9LxkLJ0LlxGuZ-sRinHonOJ0tWyjBYSCgblCRD8zBFmcId6IJUDNAcfZoi16YeMVvq8kFOZpUd6sWbr0Q5d2zyhZP1l7ZCz9QFJbUeUikrZ5pJt8A-be0a6BI9u9pPm6_nZl93bzcXHN-92ry42uqUYb1TXD4T0HCvT93iQtDOEaCIBU64xG5lqJVlGJUpyOnCtOG7BmEH1BvNOs5Pm6eoN9WqRtM2gJx28B50F4Zj0W1Kh5yu0j-F7gZTFbJMG56SHUJKglHfdsHx1RZ_9g16FEn0dQVDW1qcwRmmlXqyUjiGlCEbso51lPAiCxZKkWJIUf5Ks8JMbZVEzjLfo3-gqQFbg2jo4_Eclzs9ef16lvwEVu6nq</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Maszota‐Zieleniak, Martyna</creator><creator>Jurczak, Przemyslaw</creator><creator>Orlikowska, Marta</creator><creator>Zhukov, Igor</creator><creator>Borek, Dominika</creator><creator>Otwinowski, Zbyszek</creator><creator>Skowron, Piotr</creator><creator>Pietralik, Zuzanna</creator><creator>Kozak, Maciej</creator><creator>Szymańska, Aneta</creator><creator>Rodziewicz‐Motowidło, Sylwia</creator><general>Blackwell Publishing Ltd</general><general>Federation of European Biochemical Societies</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>OTOTI</scope><orcidid>https://orcid.org/0000-0001-7962-3953</orcidid><orcidid>https://orcid.org/0000-0002-4321-6253</orcidid><orcidid>https://orcid.org/0000-0002-8664-2041</orcidid><orcidid>https://orcid.org/0000000243216253</orcidid><orcidid>https://orcid.org/0000000286642041</orcidid><orcidid>https://orcid.org/0000000179623953</orcidid></search><sort><creationdate>202001</creationdate><title>NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution</title><author>Maszota‐Zieleniak, Martyna ; Jurczak, Przemyslaw ; Orlikowska, Marta ; Zhukov, Igor ; Borek, Dominika ; Otwinowski, Zbyszek ; Skowron, Piotr ; Pietralik, Zuzanna ; Kozak, Maciej ; Szymańska, Aneta ; Rodziewicz‐Motowidło, Sylwia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4200-b78911860bf8809a27f11c1ae026c03d3b4a154991ba6296cb604eff9b8f067c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amino acid substitution</topic><topic>Amino acids</topic><topic>Amyloid</topic><topic>Body fluids</topic><topic>Cerebral amyloid angiopathy</topic><topic>Computational fluid dynamics</topic><topic>Crystal structure</topic><topic>Crystallization</topic><topic>Crystallography</topic><topic>Cystatin C</topic><topic>Cysteine proteinase</topic><topic>Dementia disorders</topic><topic>Disulfide bonds</topic><topic>Dynamic structural analysis</topic><topic>hCC V57G variant</topic><topic>Hemorrhage</topic><topic>human cystatin C</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Papain</topic><topic>Protease inhibitors</topic><topic>protein structure</topic><topic>Proteinase inhibitors</topic><topic>Proteins</topic><topic>Stability analysis</topic><topic>Structural analysis</topic><topic>Substitutes</topic><topic>X‐ray</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maszota‐Zieleniak, Martyna</creatorcontrib><creatorcontrib>Jurczak, Przemyslaw</creatorcontrib><creatorcontrib>Orlikowska, Marta</creatorcontrib><creatorcontrib>Zhukov, Igor</creatorcontrib><creatorcontrib>Borek, Dominika</creatorcontrib><creatorcontrib>Otwinowski, Zbyszek</creatorcontrib><creatorcontrib>Skowron, Piotr</creatorcontrib><creatorcontrib>Pietralik, Zuzanna</creatorcontrib><creatorcontrib>Kozak, Maciej</creatorcontrib><creatorcontrib>Szymańska, Aneta</creatorcontrib><creatorcontrib>Rodziewicz‐Motowidło, Sylwia</creatorcontrib><creatorcontrib>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maszota‐Zieleniak, Martyna</au><au>Jurczak, Przemyslaw</au><au>Orlikowska, Marta</au><au>Zhukov, Igor</au><au>Borek, Dominika</au><au>Otwinowski, Zbyszek</au><au>Skowron, Piotr</au><au>Pietralik, Zuzanna</au><au>Kozak, Maciej</au><au>Szymańska, Aneta</au><au>Rodziewicz‐Motowidło, Sylwia</au><aucorp>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2020-01</date><risdate>2020</risdate><volume>287</volume><issue>2</issue><spage>361</spage><epage>376</epage><pages>361-376</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Human cystatin C (hCC), a member of the superfamily of papain‐like cysteine protease inhibitors, is the most widespread cystatin in human body fluids. This small protein, in addition to its physiological function, is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, stroke, and dementia. Physiologically active hCC is a monomer. However, all structural studies based on crystallization led to the dimeric structure formed as a result of a three‐dimensional exchange of the protein domains (3D domain swapping). The monomeric structure was obtained only for hCC variant V57N and for the protein stabilized by an additional disulfide bridge. With this study, we extend the number of models of monomeric hCC by an additional hCC variant with a single amino acid substitution in the flexible loop L1. The V57G variant was chosen for the X‐ray and NMR structural analysis due to its exceptional conformational stability in solution. In this work, we show for the first time the structural and dynamics studies of human cystatin C variant in solution. We were also able to compare these data with the crystal structure of the hCC V57G and with other cystatins. The overall cystatin fold is retained in the solute form. Additionally, structural information concerning the N terminus was obtained during our studies and presented for the first time.
Database
Crystallographic structure: structural data are available in PDB databases under the accession number 6ROA. NMR structure: structural data are available in PDB and BMRB databases under the accession numbers 6RPV and 34399, respectively.
Human cystatin C (hCC), a cysteine protease inhibitor, is the most widespread cystatin in human body fluids. In addition to physiological functions, it is involved in various diseases, including cerebral amyloid angiopathy, cerebral hemorrhage, and dementia. With this study, we extend the number of X‐ray and NMR structural models of monomeric hCC by an additional variant exhibiting exceptional conformational stability.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>31330077</pmid><doi>10.1111/febs.15010</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-7962-3953</orcidid><orcidid>https://orcid.org/0000-0002-4321-6253</orcidid><orcidid>https://orcid.org/0000-0002-8664-2041</orcidid><orcidid>https://orcid.org/0000000243216253</orcidid><orcidid>https://orcid.org/0000000286642041</orcidid><orcidid>https://orcid.org/0000000179623953</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1742-464X |
ispartof | The FEBS journal, 2020-01, Vol.287 (2), p.361-376 |
issn | 1742-464X 1742-4658 |
language | eng |
recordid | cdi_osti_scitechconnect_1601851 |
source | Wiley Online Library Journals Frontfile Complete; Wiley Free Content; Free Full-Text Journals in Chemistry |
subjects | Amino acid substitution Amino acids Amyloid Body fluids Cerebral amyloid angiopathy Computational fluid dynamics Crystal structure Crystallization Crystallography Cystatin C Cysteine proteinase Dementia disorders Disulfide bonds Dynamic structural analysis hCC V57G variant Hemorrhage human cystatin C NMR Nuclear magnetic resonance Papain Protease inhibitors protein structure Proteinase inhibitors Proteins Stability analysis Structural analysis Substitutes X‐ray |
title | NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A25%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NMR%20and%20crystallographic%20structural%20studies%20of%20the%20extremely%20stable%20monomeric%20variant%20of%20human%20cystatin%20C%20with%20single%20amino%20acid%20substitution&rft.jtitle=The%20FEBS%20journal&rft.au=Maszota%E2%80%90Zieleniak,%20Martyna&rft.aucorp=Argonne%20National%20Lab.%20(ANL),%20Argonne,%20IL%20(United%20States).%20Advanced%20Photon%20Source%20(APS)&rft.date=2020-01&rft.volume=287&rft.issue=2&rft.spage=361&rft.epage=376&rft.pages=361-376&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.15010&rft_dat=%3Cproquest_osti_%3E2341543322%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2341543322&rft_id=info:pmid/31330077&rfr_iscdi=true |